European Regulatory Developments on Endocrine Disruptors

The WHO defines an endocrine disruptor as ‘an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations’. This definition has been retained by the European Union, which started a number of developments to better regulate these substances in […]

Recent European Developments on Cannabis Derivatives

Cannabis derivatives such as Hemp seed oil and Cannabidiol (CBD) are very fashionable those last days and many cosmetic brands pay attention to this new market trend. As usual, new developments, new technologies and new practices raise legal questions and the European Authorities start to raise questions (and sometimes concerns) about these Cannabis derivatives. Following […]

A new piece of legislation on fragrance allergens

Important regulatory development focusing on fragrance allergens The European Commission and the trade associations (IFRA, Cosmetics Europe, UEAPME, etc.) worked for years on this future piece of legislation and its adoption is expected to take place in February 2016 although there is no certainty about the exact date. Background The European Cosmetics Regulation provides that […]

Contact

Avenue Leonard de Vinci, 14
1300 Wavre, Belgium

+32 2 888 40 10
+44 20 3866 1208

info@biorius.com

Google Maps

© Copyright - 2008 – 2021 BIORIUS